A. Szarewski

A. Szarewski, S. Rybowski, Ariane von Stenglin, 2012, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Sisters doing it for themselves

A. Szarewski, 2009, Journal of Family Planning and Reproductive Health Care.

Authors' reply

J. Cuzick, A. Szarewski, 1991 .

The use of cervicography in a primary screening service.

J. Cuzick, A. Singer, R. Edwards, 1991, British journal of obstetrics and gynaecology.

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.

C. Wheeler, H. Kitchener, M. Lehtinen, 2012, The Lancet. Oncology.

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.

C. Wheeler, H. Kitchener, M. Lehtinen, 2012, The Lancet. Oncology.

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

B Romanowski, H. Kitchener, M. Lehtinen, 2009, The Lancet.

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

Joakim Dillner, Jack Cuzick, Christian Munk, 2008, BMJ : British Medical Journal.

Barriers to cervical screening in women who have experienced sexual abuse: an exploratory study

J. Waller, A. Szarewski, L. Cadman, 2012, Journal of Family Planning and Reproductive Health Care.

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

J. Cuzick, C. Clavel, P. Birembaut, 2006, International journal of cancer.

Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04-Adjuvanted Vaccine against Cervical Infection and Precancer in Young Women: Final Event-Driven Analysis of the Randomized, Double-Blind PATRICIA Trial

C. Wheeler, H. Kitchener, M. Lehtinen, 2015, Clinical and Vaccine Immunology.

HPV Vaccination and Cervical Cancer

A. Szarewski, 2012, Current Oncology Reports.

Cervarix®: a bivalent vaccine against HPV types 16 and 18, with cross-protection against other high-risk HPV types

A. Szarewski, 2012, Expert review of vaccines.

Public awareness of human papillomavirus

H. Cubie, A. Szarewski, K. Cuschieri, 2006, Journal of medical screening.

Attitudes towards cytology and human papillomavirus self-sample collection for cervical screening among Hindu women in London, UK: a mixed methods study

J. Waller, A. Szarewski, L. Cadman, 2014, Journal of Family Planning and Reproductive Health Care.

Effect of smoking cessation on cervical lesion size

J. Cuzick, P. Sasieni, R. Edwards, 1996, The Lancet.

Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring.

D. Lowe, A. Szarewski, J. Guillebaud, 1993, European journal of obstetrics, gynecology, and reproductive biology.

Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions

J. Cuzick, M. Costa, A. Szarewski, 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Management of women who test positive for high-risk types of human papillomavirus: the HART study

U Menon, J Cuzick, G Terry, 2003, The Lancet.

Efficacy of the human papillomavirus (HPV)‐16/18 AS04‐adjuvanted vaccine in women aged 15–25 years with and without serological evidence of previous exposure to HPV‐16/18

C. Wheeler, H. Kitchener, M. Lehtinen, 2012, International journal of cancer.

Comparison of Predictors for High-Grade Cervical Intraepithelial Neoplasia in Women with Abnormal Smears

J. Cuzick, R. Dina, L. Ambroisine, 2008, Cancer Epidemiology Biomarkers & Prevention.

Differential expression of keratins 10, 17, and 19 in normal cervical epithelium, cervical intraepithelial neoplasia, and cervical carcinoma.

P. Sasieni, A. Szarewski, A. Hanby, 1999, Journal of clinical pathology.

DiVerential expression of keratins 10, 17, and 19 in normal cervical epithelium, cervical intraepithelial neoplasia, and cervical carcinoma

P. Sasieni, A. Szarewski, A. Hanby, 1998 .

Di V erential expression of keratins 10, 17, and 19 in normal cervical epithelium, cervical intraepithelial neoplasia, and cervical carcinoma

P. Sasieni, A. Szarewski, A. Hanby, 1998 .

Cytokeratin expression and acetowhite change in cervical epithelium.

J Cuzick, J. Cuzick, A. Szarewski, 1994, Journal of clinical pathology.

Comparison of Seven Tests for High-Grade Cervical Intraepithelial Neoplasia in Women with Abnormal Smears: the Predictors 2 Study

J. Cuzick, M. Stoler, D. Mesher, 2012, Journal of Clinical Microbiology.

The APTIMA HPV assay versus the hybrid capture 2 test in triage of women with ASC‐US or LSIL cervical cytology: A meta‐analysis of the diagnostic accuracy

Jack Cuzick, Marc Arbyn, Suzanne Belinson, 2013, International journal of cancer.

The effect of stopping smoking on cervical Langerhans'cells and lymphocytes

J. Cuzick, P. Royston, A. Szarewski, 2001, BJOG : an international journal of obstetrics and gynaecology.

Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and males

J. Cuzick, J. Parry, S. Beddows, 2011, Journal of medical virology.

Use of the Cytobrush for concurrent endocervical cytology and chlamydia sampling.

A. Szarewski, C. Bradbeer, J. Bertrand, 1990, Genitourinary medicine.

Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting

J. Wardle, J. Cuzick, J. Waller, 2007, Journal of medical screening.

A comparison of different human papillomavirus tests in PreservCyt versus SurePath in a referral population—PREDICTORS 4

J. Cuzick, Amar S. Ahmad, M. Stoler, 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism

J. Trussell, L. Shulman, P. Darney, 2013, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism

J. Trussell, L. Shulman, P. Darney, 2013, Journal of Family Planning and Reproductive Health Care.

Another flawed database analysis of VTE risk and hormonal contraceptives

A. Szarewski, D. Mansour, 2012, Journal of Family Planning and Reproductive Health Care.

Triage of women with minor abnormal cervical cytology: Meta‐analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high‐risk human papillomavirus types

Marc Arbyn, M. Arbyn, A. Szarewski, 2013, Cancer cytopathology.

Depo Provera. Position paper on clinical use, effectiveness and side effects.

A. Szarewski, B. Gbolade, J. Newton, 1999, The British journal of family planning.

Use of the Cytobrush for Concurrent Cytology and Chlamydia Sampling: A Comparison of Immunofluorescence and Culture for Detection of Chlamydia

J. Bertrand, A. Szarewski, R. Thin, 1991, International journal of STD & AIDS.

Exploring the acceptability of two self-sampling devices for human papillomavirus testing in the cervical screening context: a qualitative study of Muslim women in London

J. Waller, A. Szarewski, L. Cadman, 2009, Journal of medical screening.

Attitudes towards HPV testing: a qualitative study of beliefs among Indian, Pakistani, African-Caribbean and white British women in the UK

J. Wardle, J. Waller, M. Desai, 2003, British Journal of Cancer.

DMPA and bone density

A. Szarewski, J. Guillebaud, Elphis Christopher, 1991 .

Depot medroxyprogesterone acetate and osteoporosis Monitor serum oestradiol concentration in users

A. Szarewski, J. Guillebaud, B. Hollingworth, 1994, BMJ.

The use of cervicography in a primary screening service

J. Cuzick, A. Singer, R. Edwards, 1991, British journal of obstetrics and gynaecology.

Oral contraceptives, menopausal treatment, and cancer.

S. Shapiro, A. Szarewski, 2007, The Lancet. Oncology.

Janet Study with Abnormal Smears : the Predictors 2 WomenCervical Intraepithelial Neoplasia in Comparison of Seven Tests for High-Grade

M. Stoler, D. Mesher, C. Bergeron, 2012 .

Performance of the Abbott RealTime high‐risk HPV test in women with abnormal cervical cytology smears

J. Cuzick, R. Dina, L. Ambroisine, 2010, Journal of medical virology.

Attitudes to self-sampling for HPV among Indian, Pakistani, African-Caribbean and white British women in Manchester, UK

J. Wardle, J. Waller, M. Desai, 2004, Journal of medical screening.

StudyAbnormal Smears: the Predictors 2 Women Cervical Intraepithelial Neoplasia in Comparison of Seven Tests for High-Grade

J. Cuzick, M. Stoler, D. Mesher, 2012 .

New technologies and procedures for cervical cancer screening.

Jack Cuzick, Jose Jeronimo, Magnus von Knebel Doeberitz, 2012, Vaccine.

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

Jack T Stapleton, Arunachalam Ilancheran, Frank Struyf, 2014, The Lancet.

Risk of Newly Detected Infections and Cervical Abnormalities in Women Seropositive for Naturally Acquired Human Papillomavirus Type 16/18 Antibodies: Analysis of the Control Arm of PATRICIA

C. Wheeler, H. Kitchener, M. Lehtinen, 2014, The Journal of infectious diseases.

Human papillomavirus testing in primary cervical screening

J. Cuzick, A. Hanby, A. Szarewski, 1995, The Lancet.

cervical screening context : a qualitative study of Muslim women in London Exploring the acceptability of two self-sampling devices for human papillomavirus testing in the

J. Waller, A. Szarewski, L. Cadman, 2009 .

Long‐term follow‐up of cervical abnormalities among women screened by HPV testing and cytology—Results from the Hammersmith study

J. Cuzick, P. Sasieni, R. Dina, 2008, International journal of cancer.

Contraception. Current state of the art.

A. Szarewski, J. Guillebaud, 1991 .

Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions: A Systematic Review and Meta-analysis.

Jack Cuzick, Marc Arbyn, J. Cuzick, 2016, Annals of internal medicine.

Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial

C. Wheeler, M. Lehtinen, S. Garland, 2014, BMC Infectious Diseases.

Prophylactic vaccines for human papillomavirus: a bright future for cervical cancer prevention

A. Szarewski, 2005, Journal of medical screening.

Genotyping for HPV 16 and HPV 18 in women with minor cervical 1 lesions : a systematic review and meta-analysis

J. Cuzick, M. Arbyn, A. Szarewski, 2017 .

Comparison of human papillomavirus testing strategies for triage of women referred with low-grade cytological abnormalities.

J. Cuzick, M. Stoler, D. Mesher, 2013, European journal of cancer.

Cervical screening in adolescents—at least do no harm

P. Sasieni, A. Szarewski, 2004, The Lancet.

Gardasil: first vaccine for human papillomavirus infection

A. Szarewski, S. Chaplin, 2007 .

Improving the quality of communication in organised cervical cancer screening programmes.

J. Austoker, N. Segnan, M. Arbyn, 2008, Patient education and counseling.

Erratum: Testing positive for human papillomavirus in routine cervical screening: Examination of psychosocial impact (BJOG: An International Journal of Obstetrics and Gynaecology (2004) 111 (1437))

J. Wardle, J. Waller, K. McCaffery, 2004 .

The 'pill scare': the responses of authorities, doctors and patients using oral contraception.

A. Szarewski, D. Mansour, 1999, Human reproduction update.

Risk of first cervical HPV infection and precancerous lesions after onset of sexual activity Castellsague

C. Wheeler, F. X. Bosch, M. Lehtinen, 2022 .

A randomized controlled trial in non-responders from Newcastle upon Tyne invited to return a self-sample for Human Papillomavirus testing versus repeat invitation for cervical screening

A. Szarewski, R. Edwards, S. Wilkes, 2015, Journal of medical screening.

Women’s perceptions about reducing the frequency of monthly bleeding: results from a multinational survey

A. Szarewski, Cecilia Möller, 2013 .

Comprehensive control of human papillomavirus infections and related diseases.

M. Plummer, M. Poljak, J. Ferlay, 2013, Vaccine.

Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against abnormal cytology and low-grade histopathological lesions in an oncogenic HPV-naïve population

C. Wheeler, H. Kitchener, M. Lehtinen, 2009 .

Risk factors for arterial and venous thrombosis

A. Szarewski, 2008, Journal of Family Planning and Reproductive Health Care.

H. Kitchener, M. Lehtinen, X. Castellsagué, 2012, The Lancet. Oncology.

H. Kitchener, M. Lehtinen, S. Garland, 2015, Clinical and Vaccine Immunology.

The Journal of Family Planning and Reproductive Health Care - Peer Reviewers 2000

Babatunde, A. Parsons, R. Joce, 2001, Journal of Family Planning and Reproductive Health Care.

Long‐term follow‐up of cervical abnormalities among women screened by HPV testing and cytology—Results from the Hammersmith study

J. Cuzick, P. Sasieni, R. Dina, 2008, International Journal of Cancer.

Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions: A Systematic Review and Meta-analysis.

J. Cuzick, M. Arbyn, A. Szarewski, 2017, Annals of internal medicine.

Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel

H. Jick, S. Jick, A. Szarewski, 2006, Journal of Family Planning and Reproductive Health Care.

Preventing Cervical Cancer

A. Szarewski, 2007 .